AGL 37.50 Decreased By ▼ -0.08 (-0.21%)
AIRLINK 222.89 Increased By ▲ 0.46 (0.21%)
BOP 10.82 Decreased By ▼ -0.14 (-1.28%)
CNERGY 7.56 Decreased By ▼ -0.10 (-1.31%)
DCL 9.42 Decreased By ▼ -0.21 (-2.18%)
DFML 40.96 Decreased By ▼ -0.74 (-1.77%)
DGKC 106.76 Decreased By ▼ -3.99 (-3.6%)
FCCL 37.07 Decreased By ▼ -0.99 (-2.6%)
FFL 19.24 Increased By ▲ 0.95 (5.19%)
HASCOL 13.18 Decreased By ▼ -0.19 (-1.42%)
HUBC 132.64 Decreased By ▼ -2.32 (-1.72%)
HUMNL 14.73 Decreased By ▼ -0.86 (-5.52%)
KEL 5.40 Decreased By ▼ -0.16 (-2.88%)
KOSM 7.48 Increased By ▲ 0.07 (0.94%)
MLCF 48.18 Decreased By ▼ -2.15 (-4.27%)
NBP 66.29 Decreased By ▼ -0.18 (-0.27%)
OGDC 223.26 Decreased By ▼ -5.35 (-2.34%)
PAEL 43.50 Increased By ▲ 0.13 (0.3%)
PIBTL 9.07 Decreased By ▼ -0.23 (-2.47%)
PPL 198.24 Decreased By ▼ -4.89 (-2.41%)
PRL 42.24 Decreased By ▼ -0.62 (-1.45%)
PTC 27.39 Increased By ▲ 0.06 (0.22%)
SEARL 110.08 Increased By ▲ 3.06 (2.86%)
TELE 10.52 Increased By ▲ 0.74 (7.57%)
TOMCL 36.62 Decreased By ▼ -0.01 (-0.03%)
TPLP 14.95 Decreased By ▼ -0.28 (-1.84%)
TREET 26.53 Decreased By ▼ -0.26 (-0.97%)
TRG 68.85 Decreased By ▼ -1.30 (-1.85%)
UNITY 34.19 No Change ▼ 0.00 (0%)
WTL 1.79 Increased By ▲ 0.03 (1.7%)
BR100 12,363 Decreased By -32.9 (-0.27%)
BR30 38,218 Decreased By -629.2 (-1.62%)
KSE100 117,120 Increased By 111.6 (0.1%)
KSE30 36,937 Increased By 72.2 (0.2%)

LAHORE: Considering the current economic challenges and to ensure access to healthcare, Getz Pharma and M.E.D Consultants signed an MoU for the project-Dream Diabetes: SMILE (Simplifying the Life of People with Type 1 Diabetes Mellitus).

This initiative is designed to simplify the lives of underprivileged individuals living with type-1 diabetes mellitus (T1DM) through free consultations, diagnostic tests and Getz Pharma’s new insulin pen.

This project will also provide comprehensive support, including peer assistance, educational activities and medical support, regardless of their financial, educational or socioeconomic backgrounds.

“With this collaboration, Getz Pharma and M.E.D Consultants aim to make a significant impact on the lives of those affected by T1DM, fostering a community of support and knowledge for improved diabetes management. With the launch of our insulin pens, we aim to decrease the burden of diabetes and ensure that legacy meets convenience for people living with diabetes,” shared Dr. Jahanzeb Kamal, Senior Director Medical Affairs - Getz Pharma.

“Living with T1DM is an ongoing challenge for both children and adults, requiring daily management through insulin injections and blood sugar monitoring. In low-resource countries, such as Pakistan, the complexities of managing T1DM often surpass the means of the average family,” Dr. Syed Abbas Raza, CEO - M.E.D Consultants, during the ceremony, said. He added, “The primary aim of the project is to offer access to care and educational resources that empower individuals in their journey of managing T1DM.”

Additionally, the project will extend capacity-building opportunities for healthcare professionals, enhancing their skills in T1DM management. Under this project, 50 children living with T1DM will be sponsored for one year. The support will ensure they can lead healthy lives despite their economic challenges.

Copyright Business Recorder, 2024

Comments

Comments are closed.